Moderna Stock Rises on Earnings Beat and New $3 Billion Stock Buyback
Barrons.com· 7 days ago“We will continue to invest and grow as we have never been as optimistic about Moderna’s future. “...
Moderna COVID vaccine sales forecast unchanged even as COVAX program cuts orders
Reuters· 6 days agoModerna Inc (MRNA.O) on Wednesday maintained its full-year COVID-19 vaccine sales forecast of $21...
Moderna maintains vaccine sales view as demand from low-income nations eases
WSAU Wausau· 7 days ago(Reuters) - Moderna Inc on Wednesday retained its full-year sales outlook for COVID-19 shot at $21...
Moderna's Unaddressed Grey Area (NASDAQ:MRNA)
Seeking Alpha· 5 days agoModerna (NASDAQ:MRNA) beat both the top and bottom line in Q2, but upon further inspection of their earnings report, there are too many holes to be...
Moderna 'working really hard' to meet Sept. booster deadline: CEO Bancel
AOL· 7 days agoModerna (MRNA) reported a strong third quarter Wednesday, boosted by ongoing advance purchase...
Moderna Reports Second Quarter 2022 Financial Results and Provides Business Updates
Benzinga· 7 days agoSecond quarter 2022 revenues of $4.7 billion; GAAP net income of $2.2 billion and GAAP diluted EPS of $5.24Company reiterates advance purchase agreements for expected delivery in 2022 of approximately $21 billionCompany
Moderna Q2 FY 2022 Earnings Report Recap
Investopedia· 6 days agoModerna's (MRNA) Q2 earnings and revenue far exceeded analyst expectations as demand stayed strong for its COVID-19 vaccine.